Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 2Dermatologic 2CNS 2Head & Neck 1Gynecologic 1Genitourinary 1Endocrine 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 22Lung Neoplasms 11Ovarian Neoplasms 10Breast Neoplasms 9Pancreatic Neoplasms 7Colorectal Neoplasms 7Stomach Neoplasms 6Melanoma 6Neoplasm Metastasis 5Uterine Cervical Neoplasms 4Small Cell Lung Carcinoma 4Mesothelioma, Malignant 4Urogenital Neoplasms 3Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Colonic Neoplasms 3Carcinoma, Squamous Cell 3Carcinoma, Renal Cell 3Carcinoma, Merkel Cell 3Pleural Effusion, Malignant 2Liver Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Carcinoma, Adenosquamous 2Adenocarcinoma of Lung 2Adenocarcinoma 2

Interventions

pembrolizumab 7Ipilimumab 5Nivolumab 4fludarabine 3Radiosurgery 3Drug Therapy 3Cyclophosphamide 3spartalizumab 2aldesleukin 2Sirolimus 2Riluzole 2Radiotherapy 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Oncolytic Virotherapy 2Counseling 2Bupropion 2Blood Specimen Collection 2vofatamab 1utomilumab 1trastuzumab deruxtecan 1toripalimab 1tocilizumab 1sargramostim 1saracatinib 1pertuzumab 1pazopanib 1liposomal doxorubicin 1ixabepilone 1fostamatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Liver Neoplasms × aldesleukin × Thoracic × Clear all
NCT01967823 2021-03-24

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 12 charts
BreastCNSDermatologicGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Liver Neoplasms, Melanoma, Meningioma, Neoplasm Metastasis

NCT00019331 2013-06-20

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

National Cancer Institute (NCI)

Phase 2 Completed
CNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Lung Neoplasms, Melanoma, Pancreatic Neoplasms, Salivary Gland Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡